NYLIM
IOSP icon

New York Life Investment Management’s Innospec IOSP Stock Holding History

New York Life Investment Management’s Portfolio IOSP Stock Details IOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,767
Closed -$357K – 1095
2024
Q1 		$357K Sell
2,767
-595
-18% -$72.3K ﹤0.01% 1257
2023
Q4 		$414K Sell
3,362
-100
-3% -$10.6K ﹤0.01% 966
2023
Q3 		$354K Sell
3,462
-543
-14% -$56.7K ﹤0.01% 997
2023
Q2 		$402K Sell
4,005
-638
-14% -$63.9K ﹤0.01% 996
2023
Q1 		$477K Sell
4,643
-1,488
-24% -$160K 0.01% 972
2022
Q4 		$631K Buy
6,131
+659
+12% +$66.9K 0.01% 737
2022
Q3 		$469K Buy
5,472
+433
+9% +$40.9K 0.01% 797
2022
Q2 		$483K Buy
+5,039
New +$490K 0.01% 744

Other funds holding IOSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York Life Investment Management's IOSP Position: Q2 2024 in Review

New York Life Investment Management sold out of Innospec (IOSP) in Q2 2024, closing a stake of 2,767 shares — an estimated $357K sold.

New York Life Investment Management first reported a position in IOSP in Q2 2022 and held it in 8 quarters. The position peaked at $631K in Q4 2022. 265 funds tracked by Wall St. Rank hold IOSP as of Q2 2024.

  • New York Life Investment Management reported no remaining Innospec position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 2,767 Innospec shares in Q2 2024, an estimated $357K.
  • New York Life Investment Management first reported a position in Innospec in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Innospec position peaked at $631K in Q4 2022.
  • 265 funds tracked by Wall St. Rank held Innospec as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.